Keyphrases
Carbon Dots (C-dots)
100%
Hybrid Composites
100%
Vascular Disease
100%
Topical Treatment
100%
Vascular Endothelial Growth Factor
80%
Aptamer
60%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
40%
Cornea
20%
Nanomaterials
20%
Diabetic Retinopathy
20%
Commercially Available
20%
Controlled Release
20%
No Toxicity
20%
Hybrid Nanoparticles
20%
Angiogenesis
20%
Nanomedicine
20%
Ocular Diseases
20%
Carbon Modification
20%
Age-related Macular Degeneration
20%
Topical Administration
20%
Murine Animal Model
20%
Aflibercept
20%
Bevacizumab
20%
Therapeutic Levels
20%
Choroidal Blood Vessels
20%
Concentration Monitoring
20%
Back of the Eye
20%
Hybrid Carbon Materials
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nanocomposite
100%
Vasculotropin
100%
Vascular Disease
100%
Carbon Quantum Dot
83%
Aptamer
50%
Nanomaterial
16%
Controlled Release
16%
Nanoparticle
16%
Age Related Macular Degeneration
16%
Eye Disease
16%
Bevacizumab
16%
Nanomedicine
16%
Diabetic Retinopathy
16%
Aflibercept
16%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Aptamer
50%
Animal Model
16%
Angiogenesis
16%
Aflibercept
16%
Bevacizumab
16%
Chemical Engineering
Nanoparticle
100%
Nanomedicine
100%